Sequential imaging analysis using MIBG scintigraphy revealed progressive degeneration of cardiac sympathetic nerve in Parkinson's disease

European Journal of Neurology

Volumn 18, Issue 7, 2011, Pages 1010-1013

  Watanabe, M ^a   Takeda, T ^b   Nakamagoe, K ^a   Tamaoka, A ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

Biomarker; Metaiodobenzylguanidine; Myocardial post ganglionic sympathetic neuron; Noradrenergic neuron; Parkinson's disease

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123;

ADULT; ARTICLE; FEMALE; HEART NERVE; HEART SCINTISCANNING; HUMAN; IMAGE ANALYSIS; LEWY BODY; MAJOR CLINICAL STUDY; MALE; NERVE DEGENERATION; NORADRENERGIC NERVE; PARKINSON DISEASE; POWER ANALYSIS; PRIORITY JOURNAL; SYMPATHETIC NERVE;

3-IODOBENZYLGUANIDINE; AREA UNDER CURVE; FEMALE; HEART; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; MYOCARDIUM; PARKINSON DISEASE; RADIOPHARMACEUTICALS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SYMPATHETIC NERVOUS SYSTEM;

EID: 79958798387     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2010.03211.x     Document Type: Article

References (8)

1. Braune S, Reinhardt M, Schnitzer R, Riedel A, Lucking CH. Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy. Neurology 1999; 53: 1020-1025.
2. Orimo S, Ozawa E, Nakade S, Sugimoto T, Mizusawa H. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease. J Neurol Neurosurg Psychiatry 1999; 67: 189-194.
3. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184.
4. Apeldoorn L, Voerman HJ, Hoefnagel CA. Interference of MIBG uptake by medication: a case report. Neth J Med 1995; 46: 239-243.
5. Altman DG. Statistics and ethics in medical research: III How large a sample? Br Med J 1980; 281: 1336-1338.
6. Sawada H, Yamamoto K, Kitagawa N, et al. Diagnostic accuracy of cardiac metaiodobenzylguanidine scintigraphy in Parkinson disease. Eur J Neurol 2009; 16: 174-182.
7. Winogrodzka A, Bergmans P, Booij J, van Royen EA, Stoof JC, Wolters EC. [(123)I]beta-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson's disease. J Neurol Neurosurg Psychiatry 2003; 74: 294-298.
8. 18F]dopa PET. J Neurol Neurosurg Psychiatry 1998; 64: 314-319.